These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19501598)

  • 1. p38alpha MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses.
    Perry JJ; Harris RM; Moiani D; Olson AJ; Tainer JA
    J Mol Biol; 2009 Aug; 391(1):1-11. PubMed ID: 19501598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid molecules induce p38α activation via a novel molecular switch.
    Tzarum N; Eisenberg-Domovich Y; Gills JJ; Dennis PA; Livnah O
    J Mol Biol; 2012 Dec; 424(5):339-53. PubMed ID: 23079240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEF pocket in p38α facilitates substrate selectivity and mediates autophosphorylation.
    Tzarum N; Komornik N; Ben Chetrit D; Engelberg D; Livnah O
    J Biol Chem; 2013 Jul; 288(27):19537-47. PubMed ID: 23671282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders.
    Astolfi A; Manfroni G; Cecchetti V; Barreca ML
    ChemMedChem; 2018 Jan; 13(1):7-14. PubMed ID: 29210532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.
    Akella R; Min X; Wu Q; Gardner KH; Goldsmith EJ
    Structure; 2010 Dec; 18(12):1571-8. PubMed ID: 21134636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorophore labeled kinase detects ligands that bind within the MAPK insert of p38α kinase.
    Getlik M; Simard JR; Termathe M; Grütter C; Rabiller M; van Otterlo WA; Rauh D
    PLoS One; 2012; 7(7):e39713. PubMed ID: 22768308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Potential Small Molecule Binding Pockets in p38α MAP Kinase.
    Gomez-Gutierrez P; Rubio-Martinez J; Perez JJ
    J Chem Inf Model; 2017 Oct; 57(10):2566-2574. PubMed ID: 28872880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Novel Inhibitory Allosteric Site in p38α.
    Gomez-Gutierrez P; Campos PM; Vega M; Perez JJ
    PLoS One; 2016; 11(11):e0167379. PubMed ID: 27898710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of a substrate selective p38alpha inhibitor.
    Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
    Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of p38alpha MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-OUT state.
    Bukhtiyarova M; Karpusas M; Northrop K; Namboodiri HV; Springman EB
    Biochemistry; 2007 May; 46(19):5687-96. PubMed ID: 17441692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with p38α MAP kinase.
    Yang Y; Shen Y; Liu H; Yao X
    J Chem Inf Model; 2011 Dec; 51(12):3235-46. PubMed ID: 22097958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the p38α MAP kinase in complex with a docking peptide from TAB1.
    Xin F; Wu J
    Sci China Life Sci; 2013 Jul; 56(7):653-60. PubMed ID: 23722236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distinct interaction mode revealed by the crystal structure of the kinase p38α with the MAPK binding domain of the phosphatase MKP5.
    Zhang YY; Wu JW; Wang ZX
    Sci Signal; 2011 Dec; 4(204):ra88. PubMed ID: 22375048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer.
    Haar ET; Prabakhar P; Liu X; Lepre C
    J Biol Chem; 2007 Mar; 282(13):9733-9739. PubMed ID: 17255097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence polarization-based assays for detecting compounds binding to inactive c-Jun N-terminal kinase 3 and p38α mitogen-activated protein kinase.
    Ansideri F; Lange A; El-Gokha A; Boeckler FM; Koch P
    Anal Biochem; 2016 Jun; 503():28-40. PubMed ID: 26954235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two classes of p38alpha MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes.
    Michelotti EL; Moffett KK; Nguyen D; Kelly MJ; Shetty R; Chai X; Northrop K; Namboodiri V; Campbell B; Flynn GA; Fujimoto T; Hollinger FP; Bukhtiyarova M; Springman EB; Karpusas M
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5274-9. PubMed ID: 16169718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of peptide inhibitor as a therapeutic agent against head and neck squamous cell carcinoma (HNSCC) targeting p38alpha MAP kinase.
    Gill K; Singh AK; Kapoor V; Nigam L; Kumar R; Holla P; Das SN; Yadav S; Subbarao N; Mohanti BK; Dey S
    Biochim Biophys Acta; 2013 Mar; 1830(3):2763-9. PubMed ID: 23238519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases.
    Muth F; Günther M; Bauer SM; Döring E; Fischer S; Maier J; Drückes P; Köppler J; Trappe J; Rothbauer U; Koch P; Laufer SA
    J Med Chem; 2015 Jan; 58(1):443-56. PubMed ID: 25475894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p38α MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening.
    Astolfi A; Iraci N; Sabatini S; Barreca ML; Cecchetti V
    Molecules; 2015 Aug; 20(9):15842-61. PubMed ID: 26334265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.